In recent years, tumor markers such as cancer antigen (CA) 19‐9 and carcinoembryonic antigen (CEA) have shown promise for diagnosing and monitoring treatment of hilar cholangiocarcinoma. Here, CEACAM5 is linked to neoplasm.